I feel as if we have retreated to a no trials bio-tech. No phase 1, 2 let alone a soon to be 3. Absolutely loony.

Our defense is the success of our trials, their progression through the phases to approval.

There is value in all of them and big pharma will want in and when that happens we are double digits. What's going on now is nothing short (ugh) of a con.